UNRESECTABLE MALIGNANT NEOPLASM
Clinical trials for UNRESECTABLE MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for UNRESECTABLE MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy plus chemoradiation shows promise for inoperable esophageal cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug durvalumab to standard chemoradiation helps people with unresectable esophageal cancer. 112 participants received either chemoradiation alone or chemoradiation plus durvalumab, followed by durvalumab maintenance. The main go…
Matched conditions: UNRESECTABLE MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
French study checks Real-World results of new mesothelioma drug combo
Knowledge-focused CompletedThis study looked back at the medical records of 204 French patients with untreated, inoperable malignant pleural mesothelioma who received a combination of nivolumab and ipilimumab through an early access program. The goal was to see how well the treatment worked in everyday pra…
Matched conditions: UNRESECTABLE MALIGNANT NEOPLASM
Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC